ImmuCell Embarks on CEO Succession Planning Process

Core Insights - ImmuCell Corporation has initiated a search for a new President and CEO as current CEO Michael F. Brigham plans to retire by early 2026 after serving since 2000 [1][2][3] - The company aims to identify a suitable successor by the end of the year, with Brigham committed to assisting in the transition [2][3] Company Overview - ImmuCell Corporation focuses on developing, manufacturing, and marketing products that enhance the health and productivity of dairy and beef cattle [1][3] - The company’s notable products include First Defense®, which provides Immediate Immunity™ to newborn calves, and Re-Tain®, a treatment for subclinical mastitis in dairy cows [3]